XML 47 R36.htm IDEA: XBRL DOCUMENT v3.25.2
Note 4 - Business Combination (Details Textual)
$ / shares in Units, $ in Thousands
2 Months Ended 3 Months Ended
Apr. 30, 2025
USD ($)
Rate
$ / shares
shares
Jun. 30, 2025
USD ($)
Jun. 30, 2025
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Finite-Lived Intangible Asset, Useful Life (Year)   7 years 1 month 2 days 7 years 1 month 2 days 4 years 9 months  
Goodwill   $ 5,175 $ 5,175 $ 0 $ 0
Trade Names [Member]          
Finite-Lived Intangible Asset, Useful Life (Year)   2 years 9 months 29 days 2 years 9 months 29 days    
Developed Technology Rights [Member]          
Finite-Lived Intangible Asset, Useful Life (Year)   8 years 9 months 29 days 8 years 9 months 29 days    
Noncompete Agreements [Member]          
Finite-Lived Intangible Asset, Useful Life (Year)   5 years 9 months 29 days 5 years 9 months 29 days    
Evoke Neuroscience, Inc. [Member]          
Payments to Acquire Businesses, Gross $ 3,000        
Business Combination, Consideration Transferred, Equity Interest $ 2,743        
Business Combination, Price Per Share (in dollars per share) | $ / shares $ 3.5        
Business Combination, Contingent Consideration, Liability $ 478        
Business Combination, Contingent Consideration, Minimum Working Capital Threshold 90        
Post-Closing Operational Expense 150        
Business Combination, Consideration Transferred $ 6,221        
Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares (in shares) | shares 857,142        
Business Combination, Contingent Consideration, Range of Outcomes, Maximum, Amount $ 500        
Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease)     $ 3    
Goodwill $ 5,175        
Business Combination, Acquiree's Revenue since Acquisition Date, Actual   $ 251      
Business Combination, Acquiree's Earnings (Loss) since Acquisition Date, Actual   $ (12)      
Evoke Neuroscience, Inc. [Member] | Measurement Input, Discount Rate [Member]          
Business Combination, Contingent Consideration, Liability, Measurement Input (Rate) | Rate 0.036        
Evoke Neuroscience, Inc. [Member] | Measurement Input, Discount Rate [Member] | Valuation Technique, Monte Carlo Pricing Model [Member]          
Business Combination, Contingent Consideration, Liability, Measurement Input (Rate) | Rate 0.035        
Evoke Neuroscience, Inc. [Member] | Measurement Input, Assumed Income Tax Rate [Member]          
Business Combination, Contingent Consideration, Liability, Measurement Input (Rate) | Rate 0.265        
Evoke Neuroscience, Inc. [Member] | Measurement Input, Assumed Income Tax Rate [Member] | Valuation Technique, Monte Carlo Pricing Model [Member]          
Business Combination, Contingent Consideration, Liability, Measurement Input (Rate) | Rate 0.265        
Evoke Neuroscience, Inc. [Member] | Measurement Input, Price Volatility [Member]          
Business Combination, Contingent Consideration, Liability, Measurement Input (Rate) | Rate 0.024        
Evoke Neuroscience, Inc. [Member] | Measurement Input, Price Volatility [Member] | Valuation Technique, Monte Carlo Pricing Model [Member]          
Business Combination, Contingent Consideration, Liability, Measurement Input (Rate) | Rate 0.016        
Evoke Neuroscience, Inc. [Member] | Trade Names [Member]          
Finite-Lived Intangible Asset, Useful Life (Year) 3 years        
Evoke Neuroscience, Inc. [Member] | Developed Technology Rights [Member]          
Finite-Lived Intangible Asset, Useful Life (Year) 9 years        
Evoke Neuroscience, Inc. [Member] | Noncompete Agreements [Member]          
Finite-Lived Intangible Asset, Useful Life (Year) 5 years        
Evoke Neuroscience, Inc. [Member] | Noncompete Agreements [Member] | Measurement Input, Discount Rate [Member]          
Finite-Lived Intangible Assets, Measurement Input (Rate) | Rate 0.15        
Evoke Neuroscience, Inc. [Member] | Noncompete Agreements [Member] | Measurement Input, Royalty Rate [Member]          
Finite-Lived Intangible Assets, Measurement Input (Rate) | Rate 0.035        
Evoke Neuroscience, Inc. [Member] | Noncompete Agreements [Member] | Measurement Input, Assumed Income Tax Rate [Member]          
Finite-Lived Intangible Assets, Measurement Input (Rate) | Rate 0.265        
Evoke Neuroscience, Inc. [Member] | Earn Out Shares [Member]          
Business Combination, Contingent Consideration, Liability $ 500        
Business Combination, Contingent Consideration, Earnout Period (Month) 36 months